Rad50 promotes ovarian cancer progression through NF‐κB activation-Reference-Cited by-同舟云学术

Rad50 promotes ovarian cancer progression through NF‐κB activation

Published:2021-11-03 Issue:23 Volume:25 Page:10961-10972
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Li Yinuo¹,Wang Shourong¹,Li Peng¹,Li Yingwei¹,Liu Yao¹,Fang Haiya²,Zhang Xiyu¹³,Liu Zhaojian¹³^ORCID,Kong Beihua¹

Affiliation:

1. Key Laboratory of Experimental Teratology, Ministry of Education, Department of Obstetrics and Gynecology, Qilu Hospital, Department of Cell Biology, School of Basic Medical Sciences Cheeloo College of MedicineShandong University Jinan China

2. Department of Obstetrics & Gynecology Jinhua Hospital of Zhejiang University Jinhua China

3. Advanced Medical Research Institute Cheeloo College of MedicineShandong University Jinan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17017

Reference36 articles.

1. The biology of ovarian cancer: new opportunities for translation

2. ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis

3. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy

4. Integrated genomic analyses of ovarian carcinoma

5. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between DNA-damage responses and innate immunity;International Immunopharmacology;2024-10

2. PCL-seq: enhanced high-resolution transcriptomic profiling of region of interest in fresh frozen and FFPE tissues;2024-08-06

3. Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes;Computers in Biology and Medicine;2024-06

4. When DNA-damage responses meet innate and adaptive immunity;Cellular and Molecular Life Sciences;2024-04-17

5. Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50;Current Cancer Drug Targets;2024-04